Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 5;11(5):321.
doi: 10.1038/s41419-020-2498-9.

MCL-1Matrix maintains neuronal survival by enhancing mitochondrial integrity and bioenergetic capacity under stress conditions

Affiliations

MCL-1Matrix maintains neuronal survival by enhancing mitochondrial integrity and bioenergetic capacity under stress conditions

Ujval Anilkumar et al. Cell Death Dis. .

Abstract

Mitochondria play a crucial role in neuronal survival through efficient energy metabolism. In pathological conditions, mitochondrial stress leads to neuronal death, which is regulated by the anti-apoptotic BCL-2 family of proteins. MCL-1 is an anti-apoptotic BCL-2 protein localized to mitochondria either in the outer membrane (OM) or inner membrane (Matrix), which have distinct roles in inhibiting apoptosis and promoting bioenergetics, respectively. While the anti-apoptotic role for Mcl1 is well characterized, the protective function of MCL-1 Matrix remains poorly understood. Here, we show MCL-1OM and MCL-1Matrix prevent neuronal death through distinct mechanisms. We report that MCL-1Matrix functions to preserve mitochondrial energy transduction and improves respiratory chain capacity by modulating mitochondrial oxygen consumption in response to mitochondrial stress. We show that MCL-1Matrix protects neurons from stress by enhancing respiratory function, and by inhibiting mitochondrial permeability transition pore opening. Taken together, our results provide novel insight into how MCL-1Matrix may confer neuroprotection under stress conditions involving loss of mitochondrial function.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. MCL-1 protects neurons against mild mitochondrial stress induced by NMDA excitotoxicity and promotes survival of Parkin KO dopamine neurons.
a Assessment of MCL-1 expression pattern in MCL-1 ∆/- MEFs transduced with lentivirus carrying GFP, MCL-1 WT, MCL-1Matrix, and MCL-1OM. b Immunoblots from cytosolic fraction (cyto) and mitochondrial-enriched fraction (mito) in WT cortical neurons expressing GFP or MCL-1Matrix. Mitochondrial Hsp70 was observed only in mitochondrial fraction. Representative Hoechst images showing healthy (uniformly labeled) and dead (condensed) nuclei in cortical neurons expressing GFP, MCL-1Matrix or MCL-1OM in response to NMDA excitation 24 h post treatment. Scale bar 20 µm. c Cortical neurons were transduced as indicated and cell death was quantified in response to NMDA excitation 24 h post treatment (averages ± SD of nine replicates from three independent experiments). d Total ATP levels in cortical neurons expressing GFP, MCL-1Matrix or MCL-1OM in response NMDA excitation 24 h post treatment. e, f ATP in cells subjected to the same conditions as in (e) and treated with oligomycin (10 µM) for 1 h. f Total ATP levels—oligomycin sensitive ATP levels are shown (averages ± SD of nine replicates from three independent experiments). gi Cortical neurons transduced with GFP, MCL-1Matrix or MCL-1OM was treated with NMDA (100 µM/ 10 µM glycine) for 30 min and OCR was measured 24 h post excitation using a Seahorse XF24 Extracellular Flux Analyzer (g). Quantification of ATP-linked (baseline OCR minus oligomycin-insensitive OCR) (h) and Maximal respiration capacity (FCCP-induced OCR) (i) (averages ± SD of nine replicates from three independent experiments). j Representative images of primary mouse substantia nigra dopamine neurons from Parkin KO mouse showing tyrosine hydroxylase (TH) in green, MCL-1Matrix co-expressing cherry (red) and overlay of both images. k Dopamine neurons were transduced as indicated and survival was quantified at 11 days in vitro (DIV) compared to the number detected at DIV 1 after initial plating to monitor the extent of spontaneous neuronal loss in Parkin KO neurons (averages ± SD from 11–13 coverslips). Scale bar 50 µm. Data information: one-way ANOVA followed by Tukey’s post hoc test.
Fig. 2
Fig. 2. MCL-1Matrix maintains mitochondrial membrane potential in response to acute neuronal stress.
a Average TMRE traces as in neurons transduced with lentivirus carrying Control, MCL-1Matrix and MCL-1OM during NMDA excitation. b Quantification of TMRE traces in (a) at the lowest value (∆Ψm depolarization) following NMDA excitation and at different time points as indicated. c Quantification of basal TMRE fluorescence in neurons expressing Control, MCL-1Matrix, and MCL-1OM (average ± SD of 12–14 neurons from two independent experiments). Data information: one-way ANOVA followed by Tukey’s post hoc test. *P < 0.05, **P < 0.01 and ***P < 0.001.
Fig. 3
Fig. 3. MCL-1Matrix protects neurons and enhances mitochondrial bioenergetics in response to oxygen glucose deprivation.
a, b Representative Hoechst images showing healthy (uniformly labeled) and dead (condensed) nuclei in cortical neurons expressing GFP, MCL-1Matrix or MCL-1OM in response to OGD (a) and quantification of cell death is shown in (b) (averages ± SD of nine replicates from three independent experiments). ce Cortical neurons expressing GFP, MCL-1Matrix, and MCL-1OM was treated with either normoxia or oxygen glucose deprivation (OGD) for 2 h and OCR was measured 24 h post injury (c). Quantification of ATP-linked (baseline OCR minus oligomycin-insensitive OCR) (d) and Maximal respiration capacity (FCCP-induced OCR) (e) (averages ± SD of 12 replicates from three independent experiments). f, g Total ATP levels (f) and ATP synthase-driven (Total ATP levels—oligomycin sensitive) ATP levels are shown in (g) (averages ± SD of nine replicates from three independent experiment Data information: one-way ANOVA followed by Tukey’s post hoc test.
Fig. 4
Fig. 4. MCL-1Matrix regulates mitochondrial calcium retention capacity.
a, b Calcium retention capacity (CRC) in MCL-1 ∆/- MEFs expressing cherry, MCL-1OM or MCL-1Matrix exposed to consecutive pulses of Ca2+ (8.5 µM). Experiments were performed in the presence of Succinate (5 mM), Rotenone (1 µM) and Pi (10 mM) (a). Quantification of number of calcium pulses before pore opening (b) (average ± SD from four to five independent experiments). Data information: one-way ANOVA followed by Tukey’s post hoc test.
Fig. 5
Fig. 5. MCL-1Matrix regulates Mitochondrial permeability transition pore through functional interactions with ATP synthase.
a Endogenous MCL-1 was immunoprecipitated from cortical neurons lysates and the eluted samples were analyzed for MCL-1 and ATP5A expression by western blot. b Cherry (control), Alpha, Beta, Gamma, Epsilon, and C subunit of ATP synthase constructs were transiently transfected into 293 T cells. Fourty-eight hours post-transfection, cells were lysed; immunoprecipitated with anti-flag beads and analyzed by western blot. c–e) Calcium retention capacity (CRC) in MCL-1 ∆/- MEFs expressing Cherry or MCL-1Matrix and co-transduced with either ShControl or ShATP5G1 & G3. e Quantification of CRC shown in (c, d) (average ± SD from three independent experiments). Data information: one-way ANOVA followed by Tukey’s post hoc test.

References

    1. Krieger C, Duchen MR. Mitochondria, Ca2+ and neurodegenerative disease. Eur. J. Pharmacol. 2002;447:177–188. doi: 10.1016/S0014-2999(02)01842-3. - DOI - PubMed
    1. Duchen MR. Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflug. Arch. 2012;464:111–121. doi: 10.1007/s00424-012-1112-0. - DOI - PMC - PubMed
    1. Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta. 2009;1787:1416–1424. doi: 10.1016/j.bbabio.2009.03.010. - DOI - PMC - PubMed
    1. Bakthavachalam P, Shanmugam PST. Mitochondrial dysfunction - Silent killer in cerebral ischemia. J. Neurol. Sci. 2017;375:417–423. doi: 10.1016/j.jns.2017.02.043. - DOI - PubMed
    1. Manfredi G, Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion. 2005;5:77–87. doi: 10.1016/j.mito.2005.01.002. - DOI - PubMed

Publication types

MeSH terms

Substances